A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...
Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...